Supplementation of drinking water with orally available TRPV4 antagonists (Thorneloeet al., 2012) would be required to further elucidate the effects of TRPV4 blockade on cardiovascular function in endotoxaemia or sepsis. This evidence concerns the gene TRPV4 and Sepsis.